search
Back to results

Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis

Primary Purpose

Malignant Neoplasms of Male Genital Organs

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Caudal Nerve Block (CNB)
Ropivacaine
Epinephrine
Decadron
Clonidine
Propofol
Phone Call
Sponsored by
M.D. Anderson Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Malignant Neoplasms of Male Genital Organs focused on measuring Malignant neoplasms of male genital organs, Adult Penile Prosthesis Surgery, Caudal nerve block, CNB, General anesthesia, GA, Ropivacaine, Naropin, Epinephrine, Decadron, Dexamethasone, Clonidine, Propofol, Diprivan

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients that consent to participate.
  2. Patients undergoing penile prosthesis surgery.
  3. Patients that are male.
  4. Patients that are 18 years of age or older.

Exclusion Criteria:

  1. Patients on chronic pain medications (ie. Chronic = more than once every two days for greater than 2 weeks) excluding Aspirin, Acetaminophen and NSAIDs.
  2. Patients with a BMI > 40.
  3. Patients with chronic pain syndromes.
  4. Patients with hypersensitivity to Ropivacaine/amide-type anesthetics.
  5. Prior surgery of the sacrum.
  6. Patients taking anti-coagulants or other blood thinning medications prior to surgery during the specified time frames: i) Low molecular weight heparin less than 36 hours prior to surgery. ii) Coumadin less than 5 days prior to surgery. iii) Plavix and NSAIDs less than 7 days prior to surgery.
  7. Patients on any anti-seizure medications, such as gabapentin or Lyrica, specifically for chronic pain management less than 24 hours prior to surgery
  8. Patients on Celebrex less than 24 hours prior to surgery
  9. Patients taking more than 81 mg of Aspirin daily

Sites / Locations

  • University of Texas MD Anderson Cancer Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Caudal Nerve Block + General Anesthesia Group

General Anesthesia Alone Group

Arm Description

Participants receive a caudal nerve block (CNB) prior to surgery and receive general anesthesia during surgery. Study staff calls participant about 3 days after surgery.

Participants receive general anesthesia (GA) during surgery without a caudal nerve block. Study staff calls participant about 3 days after surgery.

Outcomes

Primary Outcome Measures

Post-Operative Pain Medication Usage in Post Anesthesia Care Unit (PACU)
Pain evaluated by the amount of intravenous and oral pain medicine administered in the first 24 hours post-operatively. Pain assessed using the numeric rating scale (NRS). The NRS is scored by numeric integers, 0 through 10, where 0 is no pain and 10 is the worst pain.

Secondary Outcome Measures

Post-operative Pain the First 24hrs
To determine whether the use of a CNB in patients undergoing penile prosthesis surgery results in decreased immediate postoperative pain in the first 24 hours after surgery compared with patients having only general anesthesia as determined by postop pain score. The mean, median and max pain will be assessed using the numeric rating scale (NRS). The NRS is scored by numeric integers, 0 through 10. The NRS will be used verbally. Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'
Length of Hospital Stay
To determine whether the use of a CNB in patients undergoing penile prosthesis surgery results in a decreased length of hospital stay compared with patients having only general anesthesia.

Full Information

First Posted
April 12, 2016
Last Updated
January 20, 2022
Sponsor
M.D. Anderson Cancer Center
Collaborators
Merck Sharp & Dohme LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT02740127
Brief Title
Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis
Official Title
Prospective Randomized Clinical Trial to Evaluate the Use of Caudal Nerve Blocks in Adult Penile Prosthesis Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
June 2016 (Actual)
Primary Completion Date
May 10, 2020 (Actual)
Study Completion Date
May 10, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
M.D. Anderson Cancer Center
Collaborators
Merck Sharp & Dohme LLC

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
During penile prosthesis surgery, patients are given general anesthesia in combination with other pain drugs. A caudal nerve block (CNB) is a local anesthetic injected near the tailbone, in addition to general anesthesia, which can lower the need for pain drugs. The goal of this clinical research study is to learn how effective CNBs are in patients who are having penile prosthesis surgery compared to patients who only have general anesthesia by studying how long you stay in the hospital and the level of pain you have after surgery. This is an investigational study. The general anesthesia and CNB used in this study are FDA approved and commercially available. It is considered investigational to compare the effectiveness of CNBs in penile prosthesis surgery to general anesthesia alone. The study doctor can explain how the study drugs are designed to work. Up to 104 participants will be enrolled in this study. All will take part at MD Anderson.
Detailed Description
Study Groups and CNB Administration: If you are found to be eligible to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. You will have an equal chance of being assigned to either group. If you are assigned to Group 1, you will receive a CNB and general anesthesia during surgery. If you are assigned to Group 2, you will only receive general anesthesia during surgery. You will not know to which group you have been assigned. The CNB will be given to you while you are under general anesthesia. To receive a CNB, a special needle is inserted at the lower part of the back (near the tailbone). A type of local anesthesia is then injected into the sac surrounding the spinal cord that contains the nerves related to the penis. All participants will also receive general anesthesia as part of their standard care. You will also receive a separate consent form for the surgery that explains the procedure and its risks, including the risks for general anesthesia. After Surgery Data Collection: During the 24 hours after surgery, the study staff will ask you to rate your pain on a scale of 0-10. You will be asked to rate your pain about every 30 minutes while you are in the hospital, but you may be asked to rate your pain more often if needed. It should take less than 5 minutes each time to rate your pain. Depending on how you rate your pain, additional pain drugs may be given to you as part of your standard care. If you are discharged from the hospital on the same day as your surgery or if you are discharged before a member of the staff can ask you to rate your pain, the study staff will call you within 24 hours after you have been discharged from the hospital. This call should last about 5-10 minutes. The amount of pain drugs given to you before, during, and after surgery will also be recorded. About 3 days after your surgery, the study staff will call you to ask about your pain, the amount of pain drugs you have taken, and how satisfied you are with the type of anesthesia and pain control you have received. This call should last about 5-10 minutes. Length of Study: Your participation in this study will be over after the phone call about 3 days after your surgery has been completed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malignant Neoplasms of Male Genital Organs
Keywords
Malignant neoplasms of male genital organs, Adult Penile Prosthesis Surgery, Caudal nerve block, CNB, General anesthesia, GA, Ropivacaine, Naropin, Epinephrine, Decadron, Dexamethasone, Clonidine, Propofol, Diprivan

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
52 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Caudal Nerve Block + General Anesthesia Group
Arm Type
Experimental
Arm Description
Participants receive a caudal nerve block (CNB) prior to surgery and receive general anesthesia during surgery. Study staff calls participant about 3 days after surgery.
Arm Title
General Anesthesia Alone Group
Arm Type
Active Comparator
Arm Description
Participants receive general anesthesia (GA) during surgery without a caudal nerve block. Study staff calls participant about 3 days after surgery.
Intervention Type
Procedure
Intervention Name(s)
Caudal Nerve Block (CNB)
Intervention Description
General anesthesia given in the OR using Propofol titrated for induction. CNB given as bolus injection into the caudal canal in the operating room (OR) by attending anesthesiologist using 1% Ropivacaine (max 5mg/kg) + 1:400,000 Epinephrine + Decadron 10 mg + Clonidine 100 mcg.
Intervention Type
Drug
Intervention Name(s)
Ropivacaine
Other Intervention Name(s)
Naropin
Intervention Description
Ropivacaine 1 % (max 5mg/kg) by bolus injection given by anesthesiologist in OR.
Intervention Type
Drug
Intervention Name(s)
Epinephrine
Intervention Description
Epinephrine 1:400,000 by bolus injection given by anesthesiologist in OR.
Intervention Type
Drug
Intervention Name(s)
Decadron
Other Intervention Name(s)
Dexamethasone
Intervention Description
Decadron 10 mg by bolus injection given by anesthesiologist in OR.
Intervention Type
Drug
Intervention Name(s)
Clonidine
Intervention Description
Clonidine 100 mcg by bolus injection given by anesthesiologist in OR.
Intervention Type
Drug
Intervention Name(s)
Propofol
Other Intervention Name(s)
Diprivan
Intervention Description
General anesthesia given in the OR using Propofol titrated for induction.
Intervention Type
Behavioral
Intervention Name(s)
Phone Call
Intervention Description
Study staff calls participant about 3 days after surgery to ask about their pain, amount of pain drugs they have taken, and how satisfied they are with the type of anesthesia and pain control they received. This call should last about 5-10 minutes.
Primary Outcome Measure Information:
Title
Post-Operative Pain Medication Usage in Post Anesthesia Care Unit (PACU)
Description
Pain evaluated by the amount of intravenous and oral pain medicine administered in the first 24 hours post-operatively. Pain assessed using the numeric rating scale (NRS). The NRS is scored by numeric integers, 0 through 10, where 0 is no pain and 10 is the worst pain.
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Post-operative Pain the First 24hrs
Description
To determine whether the use of a CNB in patients undergoing penile prosthesis surgery results in decreased immediate postoperative pain in the first 24 hours after surgery compared with patients having only general anesthesia as determined by postop pain score. The mean, median and max pain will be assessed using the numeric rating scale (NRS). The NRS is scored by numeric integers, 0 through 10. The NRS will be used verbally. Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'
Time Frame
24 hours
Title
Length of Hospital Stay
Description
To determine whether the use of a CNB in patients undergoing penile prosthesis surgery results in a decreased length of hospital stay compared with patients having only general anesthesia.
Time Frame
32 Hours

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients that consent to participate. Patients undergoing penile prosthesis surgery. Patients that are male. Patients that are 18 years of age or older. Exclusion Criteria: Patients on chronic pain medications (ie. Chronic = more than once every two days for greater than 2 weeks) excluding Aspirin, Acetaminophen and NSAIDs. Patients with a BMI > 40. Patients with chronic pain syndromes. Patients with hypersensitivity to Ropivacaine/amide-type anesthetics. Prior surgery of the sacrum. Patients taking anti-coagulants or other blood thinning medications prior to surgery during the specified time frames: i) Low molecular weight heparin less than 36 hours prior to surgery. ii) Coumadin less than 5 days prior to surgery. iii) Plavix and NSAIDs less than 7 days prior to surgery. Patients on any anti-seizure medications, such as gabapentin or Lyrica, specifically for chronic pain management less than 24 hours prior to surgery Patients on Celebrex less than 24 hours prior to surgery Patients taking more than 81 mg of Aspirin daily
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bobby Bellard, MD
Organizational Affiliation
M.D. Anderson Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Texas MD Anderson Cancer Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States

12. IPD Sharing Statement

Links:
URL
http://www.mdanderson.org
Description
University of Texas MD Anderson Cancer Center Website

Learn more about this trial

Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis

We'll reach out to this number within 24 hrs